Diabetes News

  • Intervention ups appropriate dysglycemia screening
    (HealthDay)—Implementation of an intervention, including electronic health record (EHR)-based decision support and training for use of the American Diabetes Association guidelines for dysglycemia screening, is associated with an increase in appropriate dysglycemia screening, according to a study published online June 15 in Diabetes Care. Read more »
  • High prevalence of diabetes, prediabetes in China
    A large, nationally representative survey in 2013 of adults in China finds that the estimated overall prevalence of diabetes was about 11 percent and that of prediabetes was nearly 36 percent, according to a study published by JAMA. Read more »
  • How insulin in the brain may suppress the subjective feeling of hunger
    Insulin in the brain may help regulate the hunger sensation and improve functional connectivity in the default-mode network (DMN), as well as in the hippocampus and hypothalamus. This is the finding of a new study by researchers at the German Center for Diabetes Research (DZD) in Tübingen. Read more »
  • Diabetes moving from affliction of affluent countries to a global problem
    The number of people with diabetes has quadrupled from 1980 to 2014, and 415 million adults in the world now have diabetes, according to Rollins researchers. Globally, it was estimated that diabetes accounted for 12 percent of health expenditures in 2010, or at least $376 billion—a figure expected to hit $490 billion in 2030. Read more »
  • sRAGE linked to risk of incident diabetic nephropathy
    (HealthDay)—Serum levels of soluble receptor for advanced glycation end products (sRAGE) are associated with the risk of developing incident diabetic nephropathy (DN) in individuals with type 1 diabetes, according to a study published online June 19 in Diabetes Care. Read more »
  • Many diabetes patients produce some insulin
    Some insulin is still produced in almost half of patients that have had type 1 diabetes for more than ten years. The study conducted by researchers at Uppsala University in Sweden has now been published online by the medical journal Diabetes Care. Read more »
  • Diabetic ketoacidosis poses fetal risk during / after event
    (HealthDay)—Diabetic ketoacidosis (DKA) during pregnancy poses risk for the fetus during and after the event, according to research published online June 12 in Diabetes Care. Read more »
  • 'Protective shield' for beta-cells suggests new option to treat diabetes
    The islets of Langerhans in the human pancreas produce and release insulin to regulate blood glucose levels. Insulin, which is specifically produced in b-cells, serves to prompt cells to take up glucose circulating in blood. Thus, insulin release lowers the level of glucose in blood. In diabetes, this cycle is disrupted by the premature death of b-cells. Working with an international team of researchers, Katarzyna Malenczyk from the Department of Molecular Neurosciences at MedUni Vienna's Center for Brain Research showed in the study published in the EMBO Journal today that the loss of a key protein, secretagogin, triggers the death of b-cells and, conversely, that these cells can be protected by increasing the amount of this protein in those suffering from diabetes. Read more »
  • Risk of cardiovascular events similar with, without diabetes
    (HealthDay)—For patients undergoing coronary angiography (CAG), those with and without diabetes without coronary artery disease (CAD) have the same risk of death, cardiac death, and myocardial infarction, according to a study published online June 8 in Diabetes Care. Read more »
  • FDA warns diabetics against use of secondhand test strips
    (HealthDay)—Millions of Americans with diabetes use glucose meters and test strips to monitor their blood sugar, but affording those supplies can be a challenge. Read more »
  • Researchers call for paradigm shift in type 2 diabetes treatment
    Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management can leave patients at risk for heart attack and stroke. But results from four recent randomized clinical trials suggest that using medications that offer glucose control while reducing the risk for cardiovascular disease could improve patient outcomes. Read more »
  • Post-ICU glucose management may improve outcomes in critical patients
    Monitoring and maintaining glucose levels of critically ill patients after admission from ICU through general care and discharge from the hospital may have positive impact on outcomes, according to findings published in the July 7, 2017 issue of the journal Mayo Clinic Proceedings. Read more »
  • PCSK9 increased in females, youth with type 1 diabetes
    (HealthDay)—Proprotein convertase subtilisin/kexin type 9 (PCSK9) is increased in young females and youth with type 1 diabetes (T1D), according to research published online June 6 in Diabetes Care. Read more »
  • Good results for zone MPC-based artificial pancreas
    (HealthDay)—A zone model predictive control (MPC)-based artificial pancreas (AP) system improves glycemic control in a home-use environment, according to a study published online June 5 in Diabetes Care. Read more »
  • Surgeon urges new focus on diabetic ulcers
    Foot ulcers are a prevalent complication for millions of people with diabetes. Estimates indicate that as many as one-third of people with the disease will develop at least one foot ulcer over the course of their lifetime. These wounds can lead to further complications such as strokes, heart attacks, infections, loss of limbs and premature death. Read more »
  • Sulforaphane in broccoli sprouts found to improve glucose levels in diabetics
    A team of researchers from Sweden, the U.S. and Switzerland has found that treating rat liver cells with a compound called sulforaphane, which is found in cruciferous vegetables, reduced production of glucose. In their paper published in Science Translational Medicine, the group outlines the methods they used to isolate the compound and what they found when testing it with liver cells and in human patients. Read more »
  • ADA: degludec noninferior for cardiovascular events in T2DM
    (HealthDay)—Among high-risk patients with type 2 diabetes, degludec is noninferior to glargine in terms of the incidence of cardiovascular events, according to a study published online June 12 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the American Diabetes Association, held from June 9 to 13 in San Diego. Read more »
  • Diabetes drug trial needs to widen participants to understand full impact of drugs
    More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research in the journal Diabetes Therapy finds. Read more »
  • Research suggests seal oil could help people with Type 1 diabetes
    A research team at the Krembil Neuroscience Centre in Toronto has published a paper that suggests seal oil has the potential to help promote nerve regeneration in patients with Type 1 diabetes. Read more »
  • The role of vitamin A in diabetes
    There has been no known link between diabetes and vitamin A - until now. A new study suggests that the vitamin improves the insulin producing β-cell´s function. Read more »
Pin It